Stromedix, Inc. clinical trials

Acquired by Biogen, Mar 8, 2012 · source ↗

The registry lists 1 studies whose lead sponsor is Stromedix, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 23, 2011.

Before and after it joined Biogen

First submitted before Stromedix, Inc. became part of Biogen: 1
First submitted after Stromedix, Inc. became part of Biogen: 0
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Withdrawn: 1

Phase

Phase 2: 1

Where

United States: 1

Registry sponsor names on this page

Stromedix, Inc.1 study

Something wrong with this grouping? Tell us on the Biogen page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Biogen studies →

Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)WithdrawnNCT00878761Phase 2
Sponsor listed in the registry: Stromedix, Inc. · First submitted before Stromedix, Inc. became part of Biogen